首页> 外文OA文献 >Concomitant or sequential administration of live attenuated japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: Randomized double-blind phase II evaluation of safety and immunogenicity

【2h】

Concomitant or sequential administration of live attenuated japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: Randomized double-blind phase II evaluation of safety and immunogenicity

机译：减毒日本脑炎嵌合病毒活疫苗和黄热病17D疫苗同时或依次给药：安全性和免疫原性的随机双盲II期评估

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

A randomized, double-blind, study was conducted to evaluate the safety, tolerability and immunogenicity of a live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) co-administered with live attenuated yellow fever (YF) vaccine (YF-17D strain; Stamaril®, Sanofi Pasteur) or administered sequentially.

机译：进行了一项随机，双盲研究，以评估减毒活的日本脑炎嵌合病毒疫苗（JE-CV）与减毒黄热病（YF）活疫苗（YF-17D菌株）的安全性，耐受性和免疫原性。 Stamaril®，Sanofi Pasteur）或依序给药。

著录项

作者
Nasveld, Peter E; Marjason, Joanne; Bennett, Sonya; Aaskov, John; Elliott, Suzanne; McCarthy, Karen; Kanesa-thasan, Niranjan; Feroldi, Emmanuel; Reid, Mark;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity. [J] . Nasveld PE, Marjason J, Bennett S, Human vaccines . 2010,第11期

机译：减毒日本脑炎嵌合病毒活疫苗和黄热病17D减毒疫苗的同时或顺序给药：安全性和免疫原性的随机双盲II期评估。
2. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax R) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-h [J] . Monath TP, Soike K, Levenbook I, Vaccine . 1999,第15a16期

机译：融合了日本脑炎（SA14-14-2）病毒的包膜基因和黄热病（17D）病毒的衣壳和非结构基因的重组，嵌合的减毒活疫苗（ChimeriVax R）在非人类中是安全，免疫原性和保护性的
3. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax R) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-h [J] . Monath TP, Soike K, Levenbook I, Vaccine . 1999,第15a16期

机译：融合了日本脑炎（SA14-14-2）病毒的包膜基因和黄热病（17D）病毒的衣壳和非结构基因的重组，嵌合的减毒活疫苗（ChimeriVax R）在非人类中是安全，免疫原性和保护性的
4. A double-blind, randomized phase II trial of thesafety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults [C] . Shelly A. McNeil, Scott A. Halperin, Joanne M. Langley, Lancefield International Symposium on Streptococci and Streptococcal Diseases . 2006

机译：一种双盲，随机期II试验，对健康成人的26岁的26岁群体的疫苗疫苗
5. The live attenuated yellow fever vaccine as a model for future vaccine design. [D] . Querec, Troy D. 2007

机译：黄热病减毒活疫苗可作为未来疫苗设计的模型。
6. Concomitant or sequential administration of live attenuated japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine [O] . Peter E Nasveld, Joanne Marjason, Sonya Bennett, 2010

机译：减毒日本脑炎嵌合病毒活疫苗和黄热病17D疫苗的同时或相继给药
7. Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine : randomized double-blind phase II evaluation of safety and immunogenicity [O] . Nasveld Peter, Marjason Joanne, Bennett Sonya, 2010

机译：减毒日本脑炎嵌合病毒活疫苗和黄热病17D疫苗的同时或顺序给药：安全性和免疫原性的随机双盲II期评估
8. Randomized Double-Blind Phase III Pivotal Field Trial of the Comparative Immunogenicity Safety and Tolerability of Two Yellow Fever 17D Vaccines (ARILVAX(Trademark) and YF-VAX(Trademark)) in Healthy Infants and Children in Peru [R] . Belmusto-Worn, V. E. , Sanchez, J. L. , McCarthy, K. , 2004

机译：秘鲁健康婴儿和儿童两种黄热病17D疫苗（aRILVaX（商标）和YF-VaX（商标））的比较免疫原性安全性和耐受性的随机双盲III期关键现场试验

Concomitant or sequential administration of live attenuated japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: Randomized double-blind phase II evaluation of safety and immunogenicity

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅